Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2019

Schedule of Change in Accounting Policy and its Impact on Key Components of Financial Statements

The following tables present the effect of the change in accounting policy and its impact on the Company’s results of operations as previously reported for the three and nine months ended September 30, 2018, as compared to the results of operations after the retrospective application of the change in accounting policy (in thousands, except share and per share amounts):

	For the Three Months Ended						For the Nine Months Ended
	September 30, 2018						September 30, 2018
	As Computed Under Straight-line Attribution Method:			As Previously Reported Under Graded Attribution Method:			As Computed Under Straight-line Attribution Method:			As Previously Reported Under Graded Attribution Method:
Operating expenses:
Research and development	$	3,467		$	3,484		$	7,909		$	8,022
General and administrative		2,865			3,681			5,781			7,170
Total operating expenses		6,332			7,165			13,690			15,192
Loss from operations		(6,332	)		(7,165	)		(13,690	)		(15,192	)
Total other income		426			426			620			620
Net loss	$	(5,906	)	$	(6,739	)	$	(13,070	)	$	(14,572	)
Net loss per share, basic and diluted	$	(0.24	)	$	(0.27	)	$	(1.16	)	$	(1.30	)
Weighted average common shares outstanding, basic and diluted		24,847,512			24,847,512			11,230,401			11,230,401

Schedule of Potential Shares Outstanding Excluded in Computation of Diluted Net Loss Per Common Share

The table below provides potential shares outstanding that were not included in the computation of diluted net loss per common share, as the inclusion of these securities would have been anti-dilutive:

	As of September 30,
	2019		2018
Shares issuable upon exercise of stock options		1,986,201		1,507,268
Non-vested shares under restricted stock grants		848,859		848,859